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The Selective Downregulation of Class I
Major Histocompatibility Complex Proteins by HIV-1
Protects HIV-Infected Cells from NK Cells
lack cell surface class I expression. NK cells are pre-
vented from killing lymphoid cells primarily by NK inhibi-
tory receptors that are specific for HLA-C and HLA-E
(reviewed in Leibson, 1998; Yokoyama, 1998; Lanier,
1998a). When engaged by the proper class I protein,
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these receptors send inhibitory signals to the NK cellMassachusetts Institute of Technology
that prevent lysis of the target cell. In contrast, the major-Cambridge, Massachusetts 02139
ity of CTL recognize peptides presented by HLA-A and²Department of Molecular and Cellular Biology
-B proteins (Littaua et al., 1991). Therefore, we wereHarvard University
interested in determining which class I MHC proteinsCambridge, Massachusetts 02138
are downregulated by HIV and whether downregulation
of class I proteins exposed HIV-infected cells to NK cell
lysis.
Two previous studies had looked at the issue of classSummary
I downregulation by HIV and both found that the HIV
protein Nef can downregulate HLA-A and -B (Collins etTo avoid detection by CTL, HIV encodes mechanisms
al., 1998; Le Gall et al., 1998). However, they came tofor removal of class I MHC proteins from the surface
different conclusions as to whether HLA-C is downregu-of infected cells. However, class I downregulation po-
lated by HIV. Le Gall et al. (1998) used cells transfectedtentially exposes the virus-infected cell to attack by
with HIV Nef alone and found that there was no downreg-NK cells. Human lymphoid cells are protected from
ulation of HLA-C in cells stained with a monoclonal anti-NK cell cytotoxicity primarily by HLA-C and HLA-E. We
body (mAb) specific for denatured HLA-C protein. Inpresent evidence that HIV-1 selectively downregulates
contrast, Collins et al. (1998) detected apparent down-HLA-A and HLA-B but does not significantly affect
regulation of HLA-C in cells infected with full-length HIVHLA-C or HLA-E. We then identify the residues in
through staining with a HLA-Cw3-specific antibody. Nei-HLA-C and HLA-E that protect them from HIV down-
ther of these studies looked at the downregulation ofregulation. This selective downregulation allows HIV-
HLA-E. Interpreting the results of these prior studies isinfected cells to avoid NK cell±mediated lysis and may
complicated by the differences in experimental tech-represent for HIV a balance between escape from CTL
niques, the paucity of antibodies specific for HLA-C,and maintenance of protection from NK cells. These
the cross-reactivity of these antibodies with other HLAresults suggest that subpopulations of CTL and NK
proteins (Zemmour et al., 1992a), and the low cell surfacecells may be uniquely suited for combating HIV.
expression level of HLA-C compared to HLA-A and -B
(Lawlor et al., 1990; Zemmour et al., 1992b). We avoid
these complications by using the well characterizedIntroduction
lymphoblastoid cell line 721.221 (221 cells) as a system
to investigate HIV downregulation of class I molecules.Viruses that infect humans have evolved mechanisms of
221 cells do not express HLA-A, -B, or -C proteins.avoiding the immune response. A component of cellular
However, upon transfection with the genes encoding
immunity, cytotoxic T lymphocytes (CTL) control viral
these alleles, 221 cells readily express class I proteins
infections by recognizing virus-encoded peptides pre-
on their surface (Shimizu and DeMars, 1989). Thus, the
sented on the surface of infected cells by class I MHC complicated processes involved in class I protein pre-
molecules. As is true for several herpes viruses (Ploegh, sentation are still intact in this cell line.
1998), human immunodeficiency virus-1 (HIV-1) regulates To study MHC protein downregulation by HIV, we cre-
cell surface expression of class I proteins (Schwartz et ated a series of 221 cell lines stably expressing both
al., 1996), and this process permits infected cells to CD4 and defined class I proteins. These cells were then
resist CTL killing (Collins et al., 1998). However, removal infected with HIV. The whole virus was used in this study
of cell surface class I proteins may expose the infected since viruses that downregulate class I proteins often
cell to attack by natural killer (NK) cells. The role of NK have multiple genes devoted to disrupting class I ex-
cells in fighting viral infections is well established (Tay pression. For example, human cytomegalovirus has at
et al., 1998). NK cells preferentially lyse target cells that least four proteins that disrupt class I presentation
(Ploegh, 1998). In HIV, three viral proteins, Nef, Vpu, and
Tat, have had ascribed to them the ability to decrease
class I cell surface levels (Howcroft et al., 1993; Schwartz³ To whom correspondence should be addressed (e-mail: baltimo@
its.caltech.edu). et al., 1996; Kerkau et al., 1997).
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mechanism that depends on Nef expression. In contrast,Hospital, Harvard Medical School, Charlestown, Massachusetts
HIV-1 does not significantly downregulate surface HLA-C02129.
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Figure 1. HIV-1 Selectively Downregulates
Class I MHC Proteins
221 cells stably expressing defined class I
proteins were infected with the NL-PI reporter
virus. At 40±48 hr post infection, these cells
were stained with a PLAP mAb (x axis) and
a pan-class I MHC mAb (y axis). The NL-PI
reporter virus used to infect these cells car-
ries the full complement of HIV-1 genes ex-
cept for (B) and (C), which used, respectively,
a Nef-minus and Vpu-minus NL-PI virus. The
infected 221 cells expressed (A) HLA-A2, (B)
HLA-A2, (C) HLA-A2, (D) HLA-B2705, and (E)
HLA-Cw4. In (F), we infect C1R cells.
-B alleles but that are not found in any HLA-C allele. little effect on HLA-A2 downregulation. HIV also down-
regulated HLA-B2705 (Figure 1D) and -B702 (data notSimilarly, a single residue substitution in the cytoplasmic
tail of HLA-E accounts for the resistance of this protein shown) in a Nef-dependent manner. The downregulation
of the HLA-B allotypes was consistently less dramaticto HIV downregulation. We then show that the HLA-C
and -E left on the surface of HIV-infected cells protects than that of HLA-A2.
In contrast, HIV infection of 221 cells that expressthe cells from NK cell lysis.
HLA-Cw4 (Figure 1E), -Cw3, or -Cw7 (data not shown)
did not result in significant class I downregulation. Simi-Results
larly, no downregulation was seen in HIV-infected 221
cells expressing the nonclassical class I MHC molecule,HIV-1 Selectively Downregulates
CD1d. These results held over a wide range of viralClass I MHC Proteins
multiplicity of infections and expression levels of the221 cells stably expressing CD4 and defined class I
class I allotypes. Similar results were obtained usingallotypes were made using retrovirus-mediated gene
HIV strain HXB-2 repaired in the Nef and Vpu readingtransfer. These stable cell lines were then infected with
frames and carrying the PLAP reporter gene. EquivalentHIV strain NL43 (NL-PI) carrying the placental alkaline
downregulation of class I protein was seen whether thephosphatase (PLAP) reporter gene (Chen et al., 1996).
cells were stained with a pan-class I MHC mAb or withInfection with NL-PI marks infected cells with the PLAP
fluorescently labeled b2-microglobulin (Davis et al.,cell surface protein. The effect of HIV infection on cell
1997) (data not shown).surface levels of class I MHC proteins was assessed
Because HIV may affect class I protein expression at40±48 hr post infection by staining for class I protein and
the transcriptional level (Howcroft et al., 1993), and thePLAP with fluorescently conjugated antibodies followed
class I alleles in 221 cells are expressed from a heterolo-by flow cytometry. Figure 1A presents results for HLA-
gous promoter, the effect of HIV on endogenous HLA-CA2-positive 221 cells (221.A2) infected with HIV NL-PI.
in the cell line C1R was also examined. C1R is a wellThree populations of cells are distinguished by the ap-
characterized cell line that expresses endogenous HLA-plied gates. In the upper left quadrant are the uninfected
Cw4, low amounts of HLA-B35 (approximately 15% ofcells. In the upper right quadrant are the cells infected
that of -Cw4), and little or no HLA-A (Zemmour et al.,with HIV that have not downregulated class I MHC. In
1992b). Therefore, the level of cell surface HLA-C in HIV-the lower right quadrant are the cells infected with HIV
infected C1R cells can be assessed with a pan-class Ithat have downregulated HLA-A2. To facilitate compari-
mAb. Following HIV infection of C1R cells, only a verysons of the extent of class I downregulation among
small amount of class I downregulation was seen, prob-different cell lines, the horizontal line that demarcates
ably due to the residual HLA-B35 (Figure 1F). We con-class I high from low cells is drawn throughout this paper
clude that HIV-1 does not downregulate HLA-C.such that 90%±95% of the uninfected cells lie above
this line (except where noted otherwise). The downregu-
Region on Class I MHC Protein Requiredlation of HLA-A2 by HIV in 221 cells is comparable to
that previously reported in HIV-infected-A2-positive pe- for Downregulation by HIV-1
To identify the region on HLA-A2 that accounted forripheral blood mononuclear cells stained with an HLA-
A2-specific monoclonal antibody (Collins et al., 1998). its Nef-dependent downregulation, a chimeric molecule
was made between human CD8a and HLA-A2. This chi-This downregulation was Nef dependent because infec-
tion with the same reporter virus having a frame shift in mera contained the extracellular region of CD8a joined
to the transmembrane (Tm) and cytoplasmic tail regionthe Nef coding region resulted in no MHC downregula-
tion (Figure 1B). Mutations in other HIV gene products of HLA-A2 (CD8a/A2-Tm&tail). Upon HIV infection, wild-
type CD8a did not undergo appreciable Nef-inducedsuch as Vpu (Figure 1C) or Vpr (data not shown) had
Protection of HIV-Infected Cells from NK Cells
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Figure 2. Region on Class I MHC Molecules
Required for Downregulation by HIV-1
221 cells expressing class I chimeric mole-
cules were infected with the NL-PI virus. The
cells were stained 40±48 hr post infection with
a PLAP mAb (x axis) and either a CD8 mAb
(2A-2B; y axis) or a pan-class I MHC mAb
(2C-2F; y axis). The infected 221 cells ex-
pressed (A) CD8a, (B) CD8a/A2(Tm&tail), (C)
HLA-Cw4/A2(Tm&tail), (D) HLA-Cw4/A2-tail,
(E) HLA-Cw4/E(Tm&tail), and (F) HLA-A2/E
(Tm&tail).
downregulation (Figure 2A), while CD8a/A2-Tm&tail was (data not shown). Attempts to assess the effect of HIV
on endogenous HLA-E using an HLA-E-specific mAbdownregulated (Figure 2B) in a Nef-dependent manner.
As with CD8a, transfer of the Tm and cytoplasmic tail (Braud et al., 1998a) were inconclusive because the
staining with this reagent was not sufficiently strong toregion of HLA-A2 to HLA-Cw4 (Cw4/A2-Tm&tail) con-
ferred Nef-dependent downregulation on Cw4 (Figure give interpretable results.
2C). Moreover, a second HLA-Cw4 and -A2 chimeric
molecule, containing only the cytoplasmic tail region of Identification of Residues in the Cytoplasmic Tails
of Class I MHC Molecules that Are CriticalHLA-A2 fused to the extracellular and Tm region of HLA-
Cw4 (Cw4/A2-tail), was downregulated by HIV (Figure for Nef-Dependent Downregulation
Since the selective downregulation of class I proteins2D) to a similar extent as HLA-Cw4/A2-Tm&tail. Chime-
ras containing either the Tm and tail of HLA-B27 joined is due to differences in the cytoplasmic tail region, we
examined this region of the molecule in more detail.to HLA-Cw4 (Cw4/B27-Tm&tail) or containing the HLA-
B27 tail alone (Cw4/B27-tail) were also downregulated Differences within the cytoplasmic tail regions of HLA-A,
-B, and -C are shown in Table 1 along with the se-(data not shown). Therefore, the cytoplasmic tail region
of HLA-C is responsible for its resistance to downregula- quences of HLA-E and CD1d. The site where the cyto-
plasmic tails were swapped to create the chimeras istion by HIV.
In contrast to the results with the HLA-Cw4/A2 shown by the arrow above the class I consensus se-
quence. Five residues of HLA-C are different from theand -Cw4/B27 chimeras, transfer of the HLA-E trans-
membrane and cytoplasmic tail region to HLA-Cw4 consensus sequence beyond this point (indicated by
dark circles, Table 1).(Cw4/E-Tm&tail; Figure 2E) or to -A2 (A2/E-Tm&tail; Fig-
ure 2F) did not permit significant Nef-dependent down- To define the residues that were critical for allowing
HLA-A and -B downregulation, point mutations wereregulation. HLA-A2 and -Cw4 chimeras containing only
the cytoplasmic tails of HLA-E (A2/E-tail and Cw4/E-tail) made in the -Cw4/B27-tail chimeric molecule. Since we
were interested in the residues in HLA-C that accountalso did not undergo Nef-dependent downregulation
Table 1. Class I MHC Cytoplasmic Tail Sequences
310 320 330 340
| ↓ | d s ss d | d d | d
Consensus RRKSSGGKGG SYSQAASSDS AQGSDVSLTA CKV
HLA-A -----DR--- ---------- ---------- ---
HLA-B ---------- ---------- ---------- ...
HLA-C ---------- -C------N- -----E--I- --A
HLA-E -K-------- ---K-EW--- ----ESHSL. ...
CD1d TSRFKRQT.. --QGVL.... .......... ...
The top row shows the class I MHC consensus sequence and is followed by the consensus sequences for HLA-A, -B, -C, and the nonclassical
class I molecules, HLA-E and CD1d. The vertical arrow above the class I consensus sequence marks the site where cytoplasmic tails were
swapped to create chimeric molecules. Dashes represent residues that match the consensus sequence. Dots are residues that are deleted
in the sequence shown. Dark circles indicate residues that differ between the consensus sequence and HLA-C. Open circles indicate residues
that differ between the consensus sequence and HLA-E that are discussed in the text. The numbering above the consensus sequence
corresponds to the residue number in HLA-Cw4.
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Figure 3. Identification of Residues in the Cy-
toplasmic Tail Region of Class I MHC Proteins
that Are Critical for Nef-Dependent Downreg-
ulation
221 cells expressing the indicated class I allo-
types were infected with the NL-PI virus and
stained for PLAP (x axis) and class I MHC (y
axis) 40±48 hr post infection. The infected 221
cells expressed (A) HLA-Cw4, (B) -Cw4/B27-
tail, (C) -Cw4/B27(Y321C), and (D) -Cw4
(C321Y). In (E)±(J), HLA-Cw4(C321Y DC3) was
further mutated to make -Cw4 progressively
more like HLA-B with the following mutations:
(E) I338T; (F) E335V; (G) N328D; (H) E335V and
I338T; (I) N328D and I338T; and (J) N328D
and E335V. In (K) and (L), the HLA-Cw4/
E-tail chimera was made more like the class I
consensus cytoplasmic tail with the following
mutations: (K) HLA-Cw4/E (QAS) contains
K323Q, E325A, and W326S; and (L) HLA-
Cw4/E (E325A).
for its resistance to Nef-induced downregulation, the single point mutation in the HLA-E cytoplasmic tail.
Thus, in addition to Tyr-321 and Asp-328, Ala-325 ismutations were made such that the HLA-B27-tail be-
came progressively more like that of HLA-C. Compared also critical for Nef-dependent downregulation of class
I proteins.to the -Cw4/B27-tail chimera (Figure 3B), the -Cw4/B27-
tail chimera containing the single point mutation Y321C
was not downregulated by HIV (Figure 3C), consistent HLA-C Protects HIV-Infected Cells from NK Lysis
To determine whether the HLA-C left on the surface ofwith previous reports that mutations at Tyr-321 abrogate
Nef-dependent downregulation (Le Gall et al., 1998) and HIV-infected cells protected infected cells from NK cells,
flow cytometry (Slezak and Horan, 1989; Collins et al.,colocalization of Nef with HLA-B (Greenberg et al., 1998).
However, inserting Tyr-321 into -Cw4 (Cw4 C321Y, Fig- 1998) was used to follow NK lysis of HIV-infected target
cells. NK-killing assays are generally done using eitherure 3D) or -Cw6 (data not shown) did not make these
molecules susceptible to HIV-induced downregulation. Cr51 or S35-methionine release as an indicator of target
cell lysis (Mandelboim et al., 1996). However, neither ofTo identify other residues necessary for conferring
Nef-dependent downregulation on HLA-C, additional the radioisotope release assays is as sensitive as flow
cytometry in discerning the killing efficiency of NK cellsmutations were made in the -Cw4(C321Y) molecule. Nei-
ther deleting the last three carboxy-terminal amino acids on a heterogeneous target cell population in which only
a fraction of the cells are HIV infected and have downreg-to make the HLA-C-tail more like HLA-B, -Cw4 (C321Y
DC3) nor changing the last amino acid to Val as it is in ulated class I MHC proteins.
Two different sources of NK cells were used as theHLA-A, -Cw4 (C321Y A342V) had any appreciable effect
(data not shown). There were only three remaining amino effector cells in these assays. First, primary NK cells
carrying the NK inhibitory receptor, NKIR1 (which is in-acids that differed between the consensus sequence
and HLA-C in the cytoplasmic tail region. All six possible hibited by a subset of HLA-C allotypes: HLA-Cw2,
-Cw4, -Cw5, and -Cw6), were cloned from peripheralcombinations of these three amino acids were made in
the context of the -Cw4 (C321Y DC3) mutant. All of the blood (Mandelboim et al., 1996). An S35 release assay
established that these NK cells (called NK.NKIR1) hadmutants that contained both C321Y and N328D were
downregulated. Mutants that did not contain both the the predicted specificity for class I proteins. Second,
we used an immortalized cell line that we geneticallytyrosine and aspartic acid were not downregulated (Fig-
ures 3E±3J). Therefore, both Tyr-321 and Asp-328 are altered to have a defined killing specificity. Prior work
(Wagtmann et al., 1995) had shown that the killing speci-critical for Nef-dependent class I downregulation.
HLA-E contains both Tyr-321 and Asp-328, yet chime- ficity of immortalized NK cells could be changed by
transferring in genes coding for NK inhibitory receptors.ras containing the cytoplasmic tail region of HLA-E were
not downregulated by HIV (Figures 2E and 2F). However, However, because vaccinia virus was used as the viral
vector, the infected NK cells lived only transiently. WeHLA-E differs from the cytoplasmic tail consensus se-
quence at a number of other residues, (Table 1) including therefore used a retrovirus vector to stably introduce
the NKIR1 gene into the YTS cell line. The resultingthree residues between Tyr-321 and Asp-328. A chime-
ric molecule containing the HLA-E cytoplasmic tail but immortalized cell line, called YTS.NKIR1, should be se-
lectively inhibited from killing target cells that expressmutated to match the class I consensus sequence at
these three residues, HLA-Cw4/E-tail (K323Q, E325A, HLA-Cw2, -Cw4, -Cw5, or -Cw6 relative to the parental
cell line (YTS), which does not express any NKIRs andW326S), was downregulated by HIV (Figure 3K). More-
over, this downregulation was retained in the mutant, therefore kills cells indiscriminately. The surface level
expression of NKIR1 in YTS.NKIR1 and NK.NKIR1 cells-Cw4/E-tail(E325A) (Figure 3L), which contains only a
Protection of HIV-Infected Cells from NK Cells
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Figure 4. HLA-Cw4 Protects HIV-Infected
Cells from NK Cell Lysis
221 cells expressing HLA-A2 alone (column
1), -A2 and -Cw3 (column 2), and -A2 and
-Cw4 (column 3) were infected with HIV car-
rying a GFP reporter, NL-GI. At 35±45 hr post
infection, the infected cells were mixed with
either YTS.NKIR1 cells (A and B), NK.KIR1
cells (C and D), or YTS cells (E) at a 4:1 ef-
fector:target cell ratio. Cells were either
stained immediately (time 5 0 hr) for GFP
(x axis) and HLA-A2 (y axis) (A) and (C) or
incubated for 6 hr at 378C (time 5 6 hr) and
then stained (B, D, and E). Not shown are YTS
cells mixed with target cells at time 0 hr as
these looked identical to the YTS.NKIR1 cells
at 0 hr (A). YTS and YTS.NKIR1 cells are unin-
fected and HLA-A2-negative and therefore
appear near the origin (lower left quadrant) in
(A), (B), and (E). The cells shown in Figures
4±6 have been electronically gated based on
light scattering to exclude dead cells. Primary
NK.NKIR1 cells are much smaller than 221
cells and have mostly been excluded from
the analysis presented in (C) and (D) based
on light-scattering properties. To facilitate
comparisons of the ability of NK cells to se-
lectively kill HIV-infected cells, the proportion
of 221.A2.Cw4 cells (column 3) that are unin-
fected (upper left quadrant), infected but have
not yet downregulated HLA-A2 (upper right
quadrant), or infected and have downregu-
lated HLA-A2 (lower right quadrant) are re-
ported in (A)±(D). No such numbers are re-
ported for 221.A2.Cw4 cells mixed with YTS
cells (E), as too few cells survive to make the
numbers meaningful.
was comparable as judged by flow cytometry (data not was added to the 221.Cw3 and 221.Cw4 cells so that
class I downregulation could be followed when theseshown). That the YTS.NKIR1 cell line had the desired
killing specificity was confirmed in NK killing assays cells were infected with HIV. These cells were infected
with HIV carrying the gene for green fluorescent proteindone using S35-release or FACS analysis (data not
shown). In these assays, YTS.NKIR1 cells efficiently lysed (NL-GI). We used GFP as the reporter construct in HIV
for these experiments because of concerns that the cell221 cells that expressed either no class I protein or
expressed HLA-A2, -B2705, or -Cw3, but they did not surface protein PLAP might influence the ability of NK
cells to recognize target cells. At 35±45 hr post infection,lyse 221 cells that expressed HLA-Cw4. In contrast, the
parental YTS cell line, lacking NKIR1 expression, lysed we mixed the target cells with YTS.NKIR1 cells (defined
as time t 5 0) and stained with an mAb specific for HLA-221.Cw4 cells as effectively as the other 221 cells (data
not shown). NK lysis of 221 target cells in the FACS A2 (Figure 4A). At this time point, the NK cells have not
yet begun to lyse the target cells. YTS cells are HLA-assay was followed based on the decrease in light-
scattering signal of cells as they die or by the uptake A2-negative and are not infected with HIV and therefore
appear in the lower left quadrant of Figure 4A. All threeof the fluorescent dye 7-aminoactinomycin D, 7AAD,
which is specific for dead cells (Schmid et al., 1994). populations of 221 target cells (columns 1±3, Figure 4A)
show signs of infection and HLA-A2 downregulation.The killing of 221 cells by NK cells in the flow cytometry
assay occurred at effector to target ratios (1:1±10:1) and The mixed effector/target cell populations were then
incubated together for 6 hr (Figure 4B). Strikingly, almostwithin times (3±6 hr) comparable to those of S35-release
assays (data not shown). all of the 221 cells that express -A2 alone or -Cw3 with
-A2 have been lysed and no longer appear in the liveThe flow cytometry NK lysis assay was then used to
test whether the HLA-C left on the surface of HIV- cell gate. In contrast, HIV-infected cells that express
-Cw4 with -A2 were protected from the YTS.NKIR1 cells.infected cells was sufficient to protect 221 cells from
NK cells. 221 cells were made that expressed either A quantitative analysis showed that -Cw4 protected 221
cells from the YTS.NKIR1 effectors regardless of theHLA-A2 alone, -A2 and -Cw3, or -A2 and -Cw4. HLA-A2
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A2-tail cells that had downregulated surface -Cw4/A2
were selectively killed, as seen by the selective loss of
the lower right-hand quadrant cells (20% in Figure 5A
and 4% in Figure 5B, column 2). Similar results were
also seen using YTS.NKIR1 cells as the effectors. In
contrast, YTS cells killed both cell populations equally
as well (data not shown). The results with the HLA-Cw4/
A2-tail chimeras show that the NK lysis flow cytometry
assay is sensitive to small changes in surface HLA-C
expression levels. We conclude that HLA-C is not down-
regulated by HIV and that the selective downregulation
of class I proteins by HIV protects HIV-infected cells
from natural killer cells.
HLA-E Protects HIV-Infected Cells
from NK Cell Lysis
Surface expression of HLA-E requires binding of a non-
amer peptide derived from the leader signal sequence
of an HLA-A, -B, or -C protein to HLA-E (Braud et al.,
Figure 5. NK.NKIR1 Cells Can Selectively Kill 221 Cells that Down-
1998a; see also Lanier, 1998a, and references within).regulate a HLA-Cw4/A2-Tail Chimera
In the absence of this nonamer peptide, HLA-E does221 cells expressing either -Cw4 (column 1) or the -Cw4/A2-tail
not efficiently make its way to the cell surface. Therefore,chimera (column 2) were infected with the NL-GI virus and mixed
although 221 cells express intracellular endogenouswith the primary NK.NKIR1 cells. Cells were either stained immedi-
ately (time 5 0 hr) for GFP (x axis) and class I MHC protein (y axis) HLA-E, unless the cells are transfected with another
(A) or incubated for 6 hr at 378C (time 5 6 hr) and then stained (B). class I MHC protein, they do not express HLA-E on the
Primary NK.NKIR1 cells are much smaller than 221 cells and have cell surface.
been excluded from the analysis presented based on light-scatter-
The NK inhibitory receptor that is specific for HLA-Eing properties. To facilitate comparisons of the ability of NK cells
is a heterodimer of CD94 and NKG2A (Borrego et al.,to kill HIV-infected cells, the proportion of 221.Cw4 and 221.A2.Cw4
1998; Braud et al., 1998b; Lee et al., 1998). One of thecells are reported in the respective quadrants.
NK cell lines that we generated from peripheral blood
was found to be largely devoid of the NK receptors,
NKIR1 and NKIR2, specific for HLA-C proteins. This cellextent of HIV infection or HLA-A2 downregulation (com-
pare the percentages in the respective quadrants of line, called NK.CD94, was therefore a good candidate
for an NK cell line specific for HLA-E. The ability of thisFigures 4A and 4B in column 3). Similar results were
seen when primary NK.NKIR1 cells were used as the cell line to lyse 221 cells expressing various MHC class
I proteins infected with HIV NL-GI was tested. In additioneffector cells (Figure 4C and 4D; primary NK.NKIR1 cells
are much smaller than 221 cells and have mostly been to infecting a number of 221 cell lines previously de-
scribed in this paper, a 221 cell line that expressed aexcluded from the analysis presented in Figures 4C and
4D based on light-scattering properties). In contrast, construct encoding the leader peptide of HLA-A2 fused
to HLA-E (HLA-A2 leader/E) was also infected. AddingYTS cells lacking NKIR1 lysed all target cell populations
indiscriminately (Figure 4E shows time 5 6 hr; the cells the HLA-A2 leader peptide to HLA-E allows surface ex-
pression of the full-length mature form of HLA-E in theat time 5 0 hr were indistinguishable from those shown
in Figure 4A and are not shown). Therefore, the NKIR1 absence of other class I proteins. Consistent with our
mutagenesis analysis, cells expressing the HLA-A2receptor is responsible for the inability of YTS.NKIR1
cells to lyse HIV-infected 221.A2.Cw4 cells. These find- leader/E protein did not show significant class I down-
regulation upon HIV infection (Figure 6A, column 3).ings indicate that the -Cw4 left on the surface of HIV-
infected cells is functional and able to protect the in- HIV-infected 221 cells that expressed either no class
I protein or expressed HLA-B2705, -Cw3, or -A2 leader/Efected cells from NK cells.
Last, we asked whether removal of -Cw4 from the were then mixed with the NK.CD94 cells for either 0 or
6 hr. HLA-B2705 contains a leader peptide that doessurface of an HIV-infected cell exposes that cell to killing
by NK cells. 221 cells expressing either the chimeric not bring HLA-E to the cell surface, HLA-Cw3 has a
leader peptide that will bring the endogenous HLA-E tomolecule, HLA-Cw4/A2-tail, or a control population of
221 cells that express Cw4 alone were infected with the surface, and HLA-A2 leader/E has a leader peptide
that will bring both the endogenous HLA-E as well asHIV. The infected cells were then mixed with NK.NKIR1
cells and either analyzed immediately (Figure 5A) or after the transfected HLA-E to the cell surface (Braud et al.,
1998a). 221 cells expressing no class I protein (data nota 6 hr incubation (Figure 5B). As expected, in the HIV-
infected 221.Cw4 cells class I protein was not downreg- shown) or HLA-B2705 were efficiently lysed by NK.CD94
regardless of HIV infection (compare Figures 6B, time 5ulated (Figure 5A, column 1). In contrast, when 221.Cw4/
A2-tail cells were infected with HIV, the chimeric mole- 0 hr, and Figure 6C, time 5 6 hr, column 1). In contrast,
221 cells expressing HLA-Cw3 or the -A2 leader/E con-cule was downregulated (Figure 5A, column 2). Follow-
ing incubation with the NK.NKIR1 cells, the 221.Cw4 struct were inefficiently lysed by NK.CD94 (compare Fig-
ures 6B, time 5 0 hr, and Figure 6C, time 5 6 hr, columncells showed little change in the relative ratios of unin-
fected to infected cells (50% were infected in both Fig- 2, -Cw3 cells; column 3, -A2 leader/E cells). Preincuba-
tion of the NK.CD94 cell line with an antibody to CD94,ures 5A and 5B, column 1). In contrast, those 221.Cw4/
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Figure 6. HLA-E Protects HIV-Infected Cells
from NK Cell Lysis
221 cells expressing HLA-B2705 (column 1),
HLA-Cw3 (column 2), and HLA-A2 leader/E
(column 3) were infected with HIV carrying a
GFP reporter, NL-GI. At 35±45 hr post infec-
tion, the infected cells were analyzed for class
I downregulation (A) or mixed with NK.CD94
cells (B±D) at effector to target cells ratios of
5:1±10:1. Cells were either stained immedi-
ately (time 5 0 hr) for GFP (x axis) and MHC
class I (y axis) (B) or incubated for 6 hr at 378C
(time 5 6 hr) and then stained (C and D). NK
cells in (D) were preincubated with an anti-
CD94 mAb to block the CD94/NKG2A interac-
tion with HLA-E. Primary NK.CD94 cells are
much smaller than 221 cells and have mostly
been excluded from the analysis presented
in (B)±(D) based on light-scattering proper-
ties. To facilitate comparisons of the ability
of NK cells to selectively kill HIV-infected
cells, the proportion of HIV-infected cells are
reported in (C) and (D). No such numbers are
reported when too few cells survive to make
the numbers meaningful.
which blocks the CD94/HLA-E interaction, reversed this downregulate HLA-C in either 221 cells or the endoge-
nous HLA-C found in C1R cells. Our results support theinhibition and promoted killing of these cells (Figure 6D).
Control antibodies, which block the interaction of NKIR1 conclusion of Schwartz and colleagues that Nef alone
does not downregulate HLA-C (Le Gall et al., 1998), andor NKIR2 with their respective ligands, had little or no
effect on the killing potential of NK.CD94 cells (data not we further demonstrate that full-length HIV also does
not downregulate HLA-C. We suspect that a previousshown). These results suggest that HIV-infected cells
expressing either HLA-Cw3 or HLA-A2 leader/E are pro- report from this laboratory (Collins et al., 1998), that in
HIV-infected cells there is a Nef-dependent downregula-tected from lysis by NK.CD94 cells through an inhibitory
signal transduced by the CD94/NKG2A complex upon tion of HLA-C, was due to cross-reactivity of the anti-
HLA-Cw3 mAb with other class I allotypes (Zemmour etHLA-E recognition.
al., 1992a; Collins and D.B., unpublished data).
Our studies suggest that in addition to HLA-C, HLA-EDiscussion
is also not downregulated by HIV. Surface expression
of HLA-E requires that the peptide presentation site onViruses that infect humans and last for the lifetime of
the host have evolved mechanisms of avoiding the HLA-E is bound to a nonamer peptide derived from the
leader signal sequence of either HLA-A, -B, or -C (seehost's CTL response. Among these mechanisms is
downregulation of surface expression of class I MHC Leibson, 1998, and references within). Since HLA-C is
not downregulated by HIV, its leader-derived nonamerprotein (Ploegh, 1998). However, downregulation of
class I MHC proteins comes with a potential cost be- peptide should be available to bring HLA-E to the
surface.cause this exposes the infected cell to NK cells. NK
killing is inhibited primarily by the presence of either In direct killing assays, we find that the HLA-C and
HLA-E left on the surface of HIV-infected cells protectsHLA-C or HLA-E and to a lesser extent by some HLA-B
alleles (Valiante et al., 1997; Lanier, 1998a; Yokoyama, those cells from NK lysis. This implies that HIV escapes
from the immune response by downregulating those1998). Given the specificity of inhibition of NK cells by
specific MHC allotypes, it was of particular interest to class I proteins recognized by the majority of known
CTL (HLA-A and -B) while retaining on the cell surfacedetermine which class I alleles are downregulated by HIV.
Using the 721.221 cell line stably infected with defined those HLA molecules that inhibit the majority of NK cells
(HLA-C and -E). This selective downregulation may rep-class I alleles, we found that HIV downregulates HLA-A
and -B alleles from the cell surface. In contrast to its resent for HIV an optimal balance of escape from CTL
and maintenance of protection from NK cells.effect on HLA-A and HLA-B, we find that HIV does not
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This strategy of selective MHC downregulation is rem- Implications
These results suggest that in vivo the majority of CTLiniscent of that used by the fetus to avoid the maternal
immune system. The MHC that the fetus carries is half (Collins et al., 1998) and NK cells will not recognize HIV-
infected cells that have selectively downregulated cellderived from the father and therefore could be recog-
nized by maternal CTL as foreign. Placental trophoblast surface class I proteins. However, small populations of
NK cells and CTL may be uniquely suited for eliminatingcells therefore do not express HLA-A or -B but do ex-
press class I proteins that inhibit NK cell lysis (Pazmany HIV-infected cells. For instance, NK cells that express
an inhibitory receptor, NKB1, specific for a subset ofet al., 1996; Lanier, 1998b, and references within). There-
fore, HIV may have adopted a strategy similar to that of HLA-B molecules, in theory, should be capable of lysing
HIV-infected cells that downregulate HLA-B if the NKthe fetus: keep those class I MHC proteins that protect
from NK cells on the surface of the cell and remove cells do not also express inhibitory receptors for HLA-C
and HLA-E. However, the in vivo importance of the NKB1those that present antigens to the most effective CTL.
inhibitory receptor in NK biology is unclear because it
is rarely expressed in the NK cells of individuals whoMechanism of Class I MHC Downregulation by Nef
carry the appropriate HLA-B ligands (Valiante et al.,We found that the ability of Nef to downregulate HLA-
1997). Interestingly, those HLA-B alleles that have beenA2 could be transferred to a heterologous cell surface
associated with a slower progression to AIDS predomi-protein, human CD8a, by replacing the Tm and cyto-
nantly belong to the subset of HLA-B alleles that areplasmic-tail sequence of CD8a with that of HLA-A2.
recognized by NKB1, while HLA-B alleles associatedThus, at least part of the Nef-induced downregulation
with a fast progression tend to belong to the subset ofis independent of peptide presentation by the class I
HLA-B alleles that are not recognized by NKB1 (Kaslowprotein, consistent with reports that Nef accelerates the
et al., 1996). There has also been a report that low NKsurface endocytosis rate of class I molecules (Schwartz
activity is associated with rapid progression to AIDSet al., 1996; Greenberg et al., 1998).
(Bruunsgaard et al., 1997). Therefore, the role of NK cellsSimilar chimeras made between HLA-Cw4 and -A2
during HIV infection warrants further study.or between HLA-Cw4 and -B27 further narrowed Nef's
There is also an unusual HLA-B allele, HLA-B4601,ability to selectively downregulate class I to the cyto-
that apparently arose from recombination between HLA-plasmic tail region of the class I protein. There is very
Cw1 and -B15. HLA-B4601 inhibits killing by NK cellslittle sequence variability within the cytoplasmic tail re-
expressing NKIR2 (like NKIR1, NKIR2 is specific for agion of class I molecules. Therefore, we have tested
subset of HLA-C allotypes) (Barber et al., 1996). How-either directly or indirectly (by using chimeric molecules)
ever, the cytoplasmic tail of HLA-B4601 matches thethe susceptibility of the vast majority of class I molecules
HLA-B consensus sequence and should be downregu-to Nef-dependent downregulation. All HLA-A and -B al-
lated by HIV. Therefore, in HLA-B4601-positive individu-leles tested were downregulated whereas all HLA-C al-
als infected with HIV, the NKIR2 NK cells may be ableleles were not.
to preferentially kill HIV-infected cells that have down-Upon further mutagenesis, we found that mutation of
regulated -B4601 if these individuals do not also containtwo residues in the cytoplasmic tail of HLA-C, C321Y
HLA-C alleles recognized by NKIR2. Thus, it will be inter-and N328D, were required to make HLA-C susceptible to
esting to determine if the HLA-B4601 allele is associatedNef-induced downregulation. All HLA-A and -B allotypes
with a slower progression to AIDS.have Tyr and Asp at these positions; all HLA-C allotypes
Similarly, just as NK cells inhibited by HLA-B mighthave Cys and Asn. Our results on Tyr-321 are in agree-
selectively be used to fight HIV, the fact that HIV leavesment with recent reports on the role of Tyr-321 in the
HLA-C on the cell surface suggests that CTL restrictedNef-dependent downregulation of HLA-B (Greenberg et
to HLA-C-presented antigens might be particularly ef-al., 1998; Le Gall et al., 1998). However, in our system,
fective at killing HIV-infected cells. However, the role ofTyr-321 was necessary but not sufficient to induce
HLA-C in CTL responses in vivo is enigmatic (Lawlor etdownregulation. Neither a -Cw4 nor a -Cw6 allotype
al., 1990). Many known CTL are restricted by HLA-Acarrying the single substitution, C321Y, was downregu-
and -B allotypes but few HLA-C-restricted CTLs havelated. Similarly, -Cw4 with the C321Y mutation and trun-
been described. This could reflect a true immunologicalcated after Ala-324 was not downregulated by HIV (un-
bias or a technical one. Few HLA-C-specific antibodiespublished data) nor was the class I MHC molecule,
exist and, therefore, typing HLA-C-restricted CTL is diffi-CD1d, which contains a tyrosine in its cytoplasmic tail
cult. Interestingly, of the few known CTL restricted tothat is required for the spontaneous endocytosis of CD1
HLA-C, many are directed against HIV antigens (Littauaproteins from the cell surface (Jackman et al., 1998).
et al., 1991; Johnson et al., 1993). There has also beenWe also found that mutation of a single amino acid
a report of HIV-positive long-term nonprogressors within the cytoplasmic tail of HLA-E, E325A, is required to
an HLA-C-restricted immunodominant CTL responsemake the -E cytoplasmic tail responsive to Nef-induced
(Nehete et al., 1998) and that HLA-C-restricted CTL oc-downregulation. Glu-325 is unique to HLA-E as all
cur frequently during the acute phase of HIV-infection (D.HLA-A, -B, and -C alleles contain an alanine at this posi-
Nixon, personal communication). That allotype-specifiction. Tyr-321, Ala-325, and Asp-328 lie within seven
populations of NK cells or CTL may be particularly effec-amino acids of each other, perhaps suggesting that this
tive in the clinical setting has been suggested by a recentregion of the class I molecule needs to adopt an a-helical
report that patients undergoing bone marrow trans-conformation for HIV-dependent downregulation. Ala-
plantation have a lower risk of a leukemia relapse if325 would lie on the same face of this proposed helix
as Tyr-321 and Asp-328. the donor marrow is mismatched at the HLA-C locus
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of the MSCV-neo vector. The MSCV.Cw4 plasmid was then digested(Sasazuki et al., 1998). This result may suggest a unique
with BamHI and XhoI to excise the cytoplasmic tail of Cw4. Therole for HLA-C within the human immune response.
cytoplasmic tail of the other class I molecules, which had beenThe failure of HIV to downregulate HLA-C and the
generated by PCR to contain a similar BamHI±XhoI site, were then
existence of HLA-C-restricted CTL raises questions cloned in to create the chimeric molecules. A similar sequence was
about the utility to the virus of class I downregulation used to create the HLA-A2/E-tail chimera and to create point muta-
tions in the cytoplasmic tail of -Cw4.as a mechanism of immune evasion. However, HLA-C
The chimeras that contain the extracellular domain of HLA-Cw4is expressed on the cell surface at lower levels than
and the Tm and cytoplasmic tail of either HLA-A2, -B27, or -E wereHLA-A and -B (Lawlor et al., 1990; Zemmour et al., 1992b)
generated directly by PCR with overlapping primers. HLA-Cw4/and CTL restricted to HLA-C-presented antigens may
A2(Tm-tail) contains residues Met-(224)-Lys-275 from Cw4 and Pro-
therefore be less effective at recognizing viral antigens 276-Val-342 from HLA-A2. HLA-Cw4/B27(Tm-tail) contains residues
due to the lower cell surface density of HLA-C. Immune Met-(224)-Trp-274 from Cw4 and Glu-275-Ala-339 from HLA-B27.
HLA-Cw4/E (Tm-tail) contains residues Met-(224)-Ser-277 fromevasion by class I downregulation would then serve as
-Cw4 and Ser-278-Leu-338 from HLA-E. The CD8a/HLA-A2 chimerica mechanism of weakening the immune response but
molecule contains the extracellular region of CD8a, Met(1)-Gly-176,would not give the virus absolute protection from the
and the Tm and cytoplasmic tail of HLA-A2, Pro-276-Val-342 (CD8a/immune system. In addition, HLA-A and -B downregula-
A2-Tm&tail). All of these constructs were cloned into the MSCV-neo
tion by HIV is not absolute and in vivo occurs concurrent vector.
with CTL recognition of class I±presented viral antigens. HIV strain HXB2 (HXB-PI) or strain NL43 (NL-PI) carrying the PLAP
reporter gene have been described (Chen et al., 1996; Collins et al.,Therefore, class I downregulation will afford the virus
1998; Gandhi et al., 1998). HIV strain NL43 carrying an enhancedonly partial protection from even HLA-A- and HLA-B-
GFP gene, NL-GI (GFP from Clonetech), is identical to NL-PI exceptrestricted CTL. However, given the enormous numbers
that GFP replaces PLAP as the reporter. NL-PI defective in Vpu (NL-of replication cycles that HIV goes through within a sin-
PI Vpu-) was generated by PCR such that the Vpu initiating ATG
gle infected individual, the selective advantage that codon was changed to CTG and the second codon of Vpu, CAA,
downregulating class I proteins confers on the virus was changed to TAA so that it encodes a premature stop codon.
All gene products generated by PCR were fully sequenced.would not have to be large to account for its existence.
Class I downregulation may then allow HIV to walk the
thin line between too little immune evasion, which would Use of Retroviruses to Create Stable Cell Lines
Retrovirus gene±mediated transfer was used to create 221 cell linesresult in decreased viral loads and transmission, and
stably expressing defined class I alleles. Retroviruses were gener-too much immune evasion, which would make the virus
ated by transfecting cultures of the packaging cell lines, Bosc (formore pathogenic and also does not favor transmission.
ecotropic viruses) or Bing (for amphotropic viruses) with retroviral
vectors. The resulting viral supernatant was then harvested and
used to infect cells as described (Pear et al., 1993; Ausubel et al.,Experimental Procedures
1996). In brief, 4 ml of viral supernatant supplemented with 4 mg/
ml hexadimethrine bromide (Sigma) was used to infect z3.0 3 105Cell Lines
221 cells. The 221 cell/virus mixture was transferred to a tissueC1R cells (Zemmour et al., 1992b), 721.221 cells (Shimizu and De-
culture plate and centrifuged for 1.5 hr at z1,000 3 g and 328C. Air-Mars, 1989), YT cells (Yoneda et al., 1992), and the retrovirus packag-
tight centrifuge rotor buckets were used when the spin-infectioning cell lines Bing and Bosc (Pear et al., 1993) are as previously
was done with amphotropic virus. After centrifugation, the cells anddescribed. YTS cells (provided by Z. Eshhar, Rehovoth, Israel) are
virus were incubated for 3±12 hr at 378C before the media wasa subline of the YT NK tumor cell line.
changed.
Stable 221 cell lines expressing CD4 and defined class I proteinsConstructs
were created by the following scheme. First, 221 cells expressingThe retroviral vectors: pM5-neo containing the mouse ecotropic
the murine ecotropic receptor were made by infecting 221 cells withreceptor (Baker et al., 1992), MSCV-neo, and pBABE-puro were
an amphotropic retrovirus carrying the mouse ecotropic receptor.used as described (Ausubel et al., 1996) except that the MSCV
Subsequently, genes could be introduced into these 221 cells withvector was modified so that it contained no BamHI site. The mouse
high efficiency using the less hazardous murine retrovirus. Approxi-ecotropic receptor was digested out of the pM5-neo vector and
mately 1 week after infecting 221 cells with the ecotropic receptor,ligated into the pBABE-puro vector to create the vector pBABE-
these cells were infected with a murine virus carrying the pBABE-ecotropic receptor-puro. The puromycin resistance gene was then
CD4-puro construct. CD4-positive 221 cells were selected in puro-deleted from this vector to create the vector pBABE-ecotropic re-
mycin and sorted by FACS for CD4 expression. These cells wereceptor without a drug selection marker.
then infected with retroviruses carrying defined class I genes. ClassThe genes for human CD8a and the class I alleles HLA-A201,
I MHC±positive 221 cells were selected in neomycin and bulk sorted-B2705, -Cw304, and -Cw401 were cloned into the MSCV-neo vec-
by FACS for class I expression. This scheme for making CD4 andtor. Human CD4 was cloned into the pBABE-puro retrovirus vector.
class I±positive 221 cells was followed for all cell lines generatedThe NKIR1 gene was cloned into the vector pBABE-puro that had
during the course of this work with the following exceptions: HLA-been modified so that expression of the Sa pac gene that confers
Cw702, -B702, -Cw6(C321Y) and CD1d. The genes for these classpuromycin resistance was driven off of the retroviral LTR. A CMV
I alleles were introduced into 221 cells by electroporation as pre-promoter driving expression of the NKIR1 gene was then inserted
viously described (Mandelboim et al., 1996).immediately downstream of the Sa pac gene. This vector was also
C1R and YTS cells carrying the CD4 and NKIR1 genes, respec-used to drive expression of the HLA-A2 leader/E construct that
tively, were generated using retroviral vectors in a procedure similarcontained the HLA-A2 leader (residues Met-(224) to Ala-(21)) joined
to the one outlined above for 221 cells.to the mature HLA-E molecule (Gly-1 to Leu-337).
Class I MHC chimeric molecules containing the extracellular and
transmembrane (Tm) portion of Cw4 and the cytoplasmic tail of HIV Infection, NK Assays, and Flow Cytometry
HIV was generated from transfected 293 cells and HIV infection ofeither HLA-A1, -A2, -B15, -B27, or HLA-E were made as follows.
PCR was used to introduce a BamHI site in the cytoplasmic tail of target cells was done as described previously (Chen et al., 1996).
NK assays were performed 35±45 hr post HIV infection. 221 targetHLA-Cw4 at residues 319 and 320. The BamHI restriction sequence,
GGA TCC, introduces a silent mutation into Cw4 as it encodes for cells (1 3 104 to 4 3 104) were mixed with NK effector cells (at the
effector to target cell ratios indicated in the text) and incubatedthe amino acids, Gly-319 and Ser-320, found in virtually all class I
proteins. This modified -Cw4 was cloned into the EcoRI±XhoI site together in a U-bottomed 96-well microtiter plate at 378C for 0±6 hr.
Immunity
670
Staining of HIV-infected cells is as described (Chen et al., 1996). Collins, K.L., Chen, B.K., Kalams, S.A., Walker, B.D., and Baltimore,
D. (1998). HIV-1 Nef protein protects infected primary cells againstHIV-infected cells were stained 40±48 hr post infection with the
following reagents: a pan-class I MHC mAb, W6/32 (Harlan Sera- killing by cytotoxic T lymphocytes. Nature 391, 397±401.
lab), rabbit anti-human PLAP (Biomeda), Cy-chrome-conjugated Davis, D.M., Reyburn, H.T., Pazmany, L., Chiu, I., Mandelboim, O.,
anti-CD8a and 7-aminoactinomycin D (PharMingen), anti-HLA-A2 and Strominger, J.L. (1997). Impaired spontaneous endocytosis of
(One Lambda), and anti-NKIR1 (Immunotech). Secondary antibodies HLA-G. Eur. J. Immunol. 27, 2714±2719.
were goat anti-mouse IgG FITC and goat anti-rabbit IgG PE (Caltag). Gandhi, R.T., Chen, B.K., Straus, S.E., Dale, J.K., Lenardo, M.J., and
Stained HIV-infected cells were fixed overnight with 2% formalde- Baltimore, D. (1998). HIV-1 directly kills CD41 T cells by a Fas-
hyde in phosphate-buffered saline at 48C. NK receptor blocking independent mechanism. J. Exp. Med. 187, 1113±1122.
antibodies were: HP3E4, anti-NKIR1 (Perez-Villar et al., 1997);
Greenberg, M.E., Iafrate, A.J., and Skowronski, J. (1998). The SH3GL183, anti-NKIR2 (Immunotech); and HP-3D9, anti-CD94 (Phar-
domain-binding surface and an acidic motif in HIV-1 Nef regulateMingen). Blocking of NK inhibitory receptors was done using 2±5
trafficking of class I MHC complexes. EMBO J. 17, 2777±2789.mg of mAb mixed with NK cells on ice for 30 min prior to incubation
Howcroft, T.K., Strebel, K., Martin, M.A., and Singer, D.S. (1993).with target cells at 378C. Results shown are typical of at least dupli-
Repression of MHC class I gene promoter activity by two-exon Tatcate experiments.
of HIV. Science 260, 1320±1322.
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